Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Twinbeech Capital LP

Twinbeech Capital LP lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 45.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 66,637 shares of the company's stock after selling 56,270 shares during the period. Twinbeech Capital LP's holdings in Ryan Specialty were worth $4,275,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of RYAN. Two Sigma Advisers LP increased its stake in Ryan Specialty by 693.3% in the 4th quarter. Two Sigma Advisers LP now owns 35,700 shares of the company's stock valued at $2,291,000 after purchasing an additional 31,200 shares in the last quarter. Two Sigma Investments LP increased its stake in shares of Ryan Specialty by 114.9% during the 4th quarter. Two Sigma Investments LP now owns 204,817 shares of the company's stock worth $13,141,000 after purchasing an additional 109,522 shares in the last quarter. ProShare Advisors LLC raised its position in shares of Ryan Specialty by 11.6% during the 4th quarter. ProShare Advisors LLC now owns 4,979 shares of the company's stock worth $319,000 after purchasing an additional 519 shares during the last quarter. Quantinno Capital Management LP lifted its stake in Ryan Specialty by 5.9% in the 4th quarter. Quantinno Capital Management LP now owns 14,163 shares of the company's stock valued at $909,000 after buying an additional 783 shares in the last quarter. Finally, Nomura Holdings Inc. acquired a new stake in Ryan Specialty during the 4th quarter valued at $906,000. Institutional investors and hedge funds own 84.82% of the company's stock.

Analysts Set New Price Targets

RYAN has been the topic of several recent research reports. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and upped their price objective for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. Barclays cut their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Morgan Stanley lifted their price target on shares of Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday, May 19th. Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Finally, Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $75.58.

Insider Buying and Selling

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 52.21% of the stock is currently owned by corporate insiders.

Ryan Specialty Trading Down 0.0%

RYAN traded down $0.03 on Monday, reaching $68.69. 548,694 shares of the company's stock were exchanged, compared to its average volume of 985,615. Ryan Specialty Holdings, Inc. has a twelve month low of $52.34 and a twelve month high of $77.16. The company's 50 day moving average is $70.10 and its 200-day moving average is $68.77. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $18.03 billion, a price-to-earnings ratio of 99.56, a PEG ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. During the same period in the previous year, the firm earned $0.35 earnings per share. Ryan Specialty's revenue for the quarter was up 25.0% on a year-over-year basis. Equities analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.70%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.